 |
| Opinion | Top |
 |
 |
 |
| Editorials |
 |
 |
 |
Why buy biotech? p111 doi:10.1038/6072 Full text | PDF
(64K)
|
 |
 |
 |
Signal transduction 2000 p111 doi:10.1038/6073 Full text | PDF
(64K)
|
 |
 |
 |
| Commentary |
 |
 |
 |
Five stages of the Human Genome Project p112 Richard C. Strohman doi:10.1038/6074 Full text | PDF
(60K)
|
 |
 |
 |
The real curse of Frankenfood p113 Henry I. Miller doi:10.1038/6075 Full text | PDF
(54K)
|
 |
 |
 |
Core ethical values for European bioindustries pp114 - 115 Robin Fears
& Erik Tambuyzer doi:10.1038/6076 Full text | PDF
(64K)
|
 |
| In Brief | Top |
 |
 |
 |
| Business and Regulatory News |
 |
 |
 |
New plan from industry to preserve Bt crops p117 Jeff Fox doi:10.1038/6077 Full text | PDF
(282K)
|
 |
 |
 |
Another hiccup at British Biotech p117 Adam Michael doi:10.1038/6079 Full text | PDF
(282K)
|
 |
 |
 |
More merger of markets p117 Adam Michael doi:10.1038/6080 Full text | PDF
(282K)
|
 |
 |
 |
15 years agoFebruary 1984 p117 Emma Dorey doi:10.1038/6081 Full text | PDF
(282K)
|
 |
 |
 |
Initial public offerings, 4th quarter 1998 p118 doi:10.1038/6082 Full text | PDF
(80K)
|
 |
 |
 |
Biopharmaceutical sector performance 4th quarter 1998 p118 doi:10.1038/6084 Full text | PDF
(80K)
|
 |
 |
 |
UK news is good and bad p118 Adam Michael doi:10.1038/6087 Full text | PDF
(80K)
|
 |
 |
 |
Flu deal is nothing to sneeze at p118 Emma Dorey doi:10.1038/6089 Full text | PDF
(80K)
|
 |
 |
 |
Biotechnology fundraising, Q4 1998 v. Q3 1998 p118 doi:10.1038/6090 Full text | PDF
(80K)
|
 |
 |
 |
A rotten year for funding p118 Adam Michael doi:10.1038/6093 Full text | PDF
(80K)
|
 |
 |
 |
Tapping into Mexican plants p119 Adam Michael doi:10.1038/6095 Full text | PDF
(49K)
|
 |
 |
 |
A knock for genomics p119 Vicki Brower doi:10.1038/6096 Full text | PDF
(49K)
|
 |
 |
 |
Human clone update p119 Asako Saegusa doi:10.1038/6097 Full text | PDF
(49K)
|
 |
 |
 |
Research collaborations p119 doi:10.1038/6098 Full text | PDF
(49K)
|
 |
 |
 |
| Research News |
 |
 |
 |
Panning for Taxol−binding proteins p120 LeeAnn Leshko doi:10.1038/6099 Full text | PDF
(70K)
|
 |
 |
 |
A Crick in the elbow p120 Alan Dove doi:10.1038/6101 Full text | PDF
(70K)
|
 |
 |
 |
Gene therapy on demand p120 Alan Dove doi:10.1038/6102 Full text | PDF
(70K)
|
 |
 |
 |
Breathing easier with AAT deficiency p120 Margret Einarson doi:10.1038/6103 Full text | PDF
(70K)
|
 |
 |
 |
Predicting protein function p120 Alan Dove doi:10.1038/6104 Full text | PDF
(70K)
|
 |
 |
 |
| This Month in Biotechnology |
 |
 |
 |
Fab direction for AAV p121 Andrew Marshall doi:10.1038/6105 Full text | PDF
(102K)
|
 |
 |
 |
A new twist on protein folding p121 Andrew Marshall doi:10.1038/6107 Full text | PDF
(102K)
|
 |
 |
 |
Bladder in a dish p121 Andrew Marshall doi:10.1038/6108 Full text | PDF
(102K)
|
 |
 |
 |
PDZ domains to order p121 Andrew Marshall doi:10.1038/6110 Full text | PDF
(102K)
|
 |
 |
 |
Low−lactose transgenic milk p121 Andrew Marshall doi:10.1038/6112 Full text | PDF
(102K)
|
 |
 |
 |
Photopolymerizable bone substitute p121 Andrew Marshall doi:10.1038/6113 Full text | PDF
(102K)
|
 |
 |
 |
Optimizing Mab function p121 Andrew Marshall doi:10.1038/6114 Full text | PDF
(102K)
|
 |
 |
 |
Ironing out plant stress p121 Andrew Marshall doi:10.1038/6293 Full text | PDF
(102K)
|
 |
| Analysis | Top |
 |
 |
 |
| Business and Regulatory News |
 |
 |
 |
Delegates face many challenges negotiating Biosafety Protocol p123 Jeffrey L. Fox doi:10.1038/6116 Full text | PDF
(70K)
|
 |
 |
 |
Amgen's NESP victory cuts out Johnson & Johnson p124 Ingeborg Fürst doi:10.1038/6117 Full text | PDF
(84K)
|
 |
 |
 |
EST patent granted for human kinase homologs p125 Debra Robertson doi:10.1038/6119 Full text | PDF
(121K)
|
 |
 |
 |
Companies chase money in and out of the Eurozone pp125 - 126 Adam Michael doi:10.1038/6120 Full text | PDF
(127K)
|
 |
 |
 |
Japanese budget boosts biotech pp126 - 127 Asako Saegusa doi:10.1038/6122 Full text | PDF
(94K)
|
 |
 |
 |
deCODE looks forward as database law passes p127 John Hodgson doi:10.1038/6124 Full text | PDF
(85K)
|
 |
 |
 |
Will investors return to biotechnology? p128 Emma Dorey doi:10.1038/6126 Full text | PDF
(72K)
|
 |
 |
 |
Asthma targets: Research dilemma pp128 - 129 Alan Dove doi:10.1038/6127 Full text | PDF
(76K)
|
 |
 |
 |
| Research News and Views |
 |
 |
 |
RASSLing with receptors pp131 - 132 Tim Clackson doi:10.1038/6128 Full text | PDF
(151K)
|
 |
 |
 |
The PDZ domain as you like it pp132 - 133 Robert E. Hughes
& Stanley Fields doi:10.1038/6130 Full text | PDF
(237K)
|
 |
 |
 |
Reconstructing the urinary bladder pp133 - 134 Christian Lorenz
& Birgit Margareta Schaefer doi:10.1038/6132 Full text | PDF
(334K)
|
 |
 |
 |
Toward designer milk pp135 - 136 Bruce Whitelaw doi:10.1038/6134 Full text | PDF
(101K)
|
 |
 |
 |
Ironing out the protein folding problem? pp136 - 137 Paul M. Horowitz doi:10.1038/6136 Full text | PDF
(90K)
|
 |
 |
 |
Metabolic engineers in the Bavarian Alps pp137 - 138 Philip A. Lessard, Mary Callan
& Guy della−Cioppa doi:10.1038/6138 Full text | PDF
(160K)
|
 |
| Feature | Top |
 |
 |
 |
Human ES cells: Can you build a business around them? pp139 - 142 Vicki Brower doi:10.1038/6140 Abstract | Full text | PDF
(159K)
|
 |
| Research Review | Top |
 |
 |
 |
Improving enzymes for cancer gene therapy pp143 - 147 Lance P. Encell, Daniel M. Landis
& Lawrence A. Loeb doi:10.1038/6142 Abstract | Full text | PDF
(104K)
|
 |
| Research Articles | Top |
 |
 |
 |
De novo reconstitution of a functional mammalian urinary bladder by tissue
engineering pp149 - 155 Frank Oberpenning, Jun Meng, James J. Yoo
& Anthony Atala doi:10.1038/6146 Abstract | Full text | PDF
(598K)
|
 |
 |
 |
Photopolymerizable degradable polyanhydrides with osteocompatibility pp156 - 159 Kristi S. Anseth, Venkatram R. Shastri
& Robert Langer doi:10.1038/6152 Abstract | Full text | PDF
(261K)
|
 |
 |
 |
Production of low-lactose milk by ectopic expression of intestinal lactase in the mouse mammary gland pp160 - 164 Bernard Jost, Jean−Luc Vilotte, Isabelle Duluc, Jean−Luc Rodeau
& Jean−Noël Freund doi:10.1038/6158 Abstract | Full text | PDF
(242K)
|
 |
 |
 |
Conditional expression and signaling of a specifically designed G
i-coupled receptor in transgenic mice pp165 - 169 Charles H. Redfern, Peter Coward, Michael Y. Degtyarev, Elena K. Lee, Andrew T. Kwa, Lothar Hennighausen, Hermann Bujard, Glenn I. Fishman
& Bruce R. Conklin doi:10.1038/6165 Abstract | Full text | PDF
(243K)
|
 |
 |
 |
Mutagenesis and selection of PDZ domains that bind new protein targets
pp170 - 175 Stefan Schneider, Michael Buchert, Oleg Georgiev, Bruno Catimel, Michael Halford, Steven A. Stacker, Thomas Baechi, Karin Moelling
& Christopher M. Hovens doi:10.1038/6172 Abstract | Full text | PDF
(618K)
|
 |
 |
 |
Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent
cellular cytotoxic activity pp176 - 180 Pablo Umaña, Joël Jean−Mairet, Radmila Moudry, Hanspeter Amstutz
& James E. Bailey doi:10.1038/6179 Abstract | Full text | PDF
(136K)
|
 |
 |
 |
Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab' )2 antibody pp181 - 186 Jeffrey S. Bartlett, Jurgen Kleinschmidt, Richard C. Boucher
& R. Jude Samulski doi:10.1038/6185 Abstract | Full text | PDF
(144K)
|
 |
 |
 |
Oxidative refolding chromatography: folding of the scorpion toxin Cn5 pp187 - 191 Myriam M. Altamirano, Consuelo García, Lourival D. Possani
& Alan R. Fersht doi:10.1038/6192 Abstract | Full text | PDF
(161K)
|
 |
 |
 |
Plants ectopically expressing the ironbinding protein, ferritin, are
tolerant to oxidative damage and pathogens pp192 - 196 Mária Deák, Gábor V. Horváth, Sholpan Davletova, Katalin Török, László Sass, Imre Vass, Balázs Barna, Zoltán Király
& Dénes Dudits doi:10.1038/6198 Abstract | Full text | PDF
(295K)
|
 |
| Resources | Top |
 |
 |
 |
| Patents |
 |
 |
 |
Intellectual property protection for plants pp197 - 198 Cheryl H. Agris doi:10.1038/6205 Full text | PDF
(113K)
|
 |
 |
 |
Recent patent applications in peptide nucleic acids p199 doi:10.1038/6207 Full text | PDF
(39K)
|
 |
 |
 |
| In the Laboratory |
 |
 |
 |
Detection and sizing of telomeric repeat DNA in situ pp200 - 201 Nedime Serakinci
& Jørn Koch doi:10.1038/6209 Abstract | Full text | PDF
(82K)
|
 |
 |
 |
| Internet |
 |
 |
 |
Clinical trials p202 Michael Francisco doi:10.1038/6211 Full text | PDF
(69K)
|
 |
 |
 |
| People |
 |
 |
 |
People p203 doi:10.1038/6213 Full text | PDF
(67K)
|
 |
 |
 |
| New Products |
 |
 |
 |
Chromatography p204 doi:10.1038/6215 Full text | PDF
(109K)
|
 |
 |
 |
| Industry Trends |
 |
 |
 |
Xenotransplantation pp205 - 206 Aris Persidis doi:10.1038/6222 Full text | PDF
(68K)
|
 |
Top |
 |
 |